SEC Company Response from CONEXANT SYSTEMS INC (CIK 0001069353) — Jul 25, 2005
CONEXANT SYSTEMS INC (CIK 0001069353)
Date: July 25, 2005 · CIK: 0001069353 · Accession: 0000893838-05-000184
AI Filing Summary & Sentiment
File numbers found in text: 000-24923
Referenced dates: June 22, 2005
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Conexant Systems, Inc.
4000 MacArthur Boulevard, West Tower
Newport Beach, California 92660
July 25, 2005
Securities and Exchange
Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Re:
Conexant Systems, Inc.
Form 8-K dated April 20, 2005
File No. 000-24923
Ladies and Gentlemen:
This
letter is in response to the comment of the staff (the “Staff”) of the
Securities and Exchange Commission (the “SEC”) made in the letter dated June 22,
2005 (the “Comment Letter”) from Lynn Dicker, Review Accountant, Division of
Corporation Finance of the SEC, to J. Scott Blouin, Senior Vice President and Chief
Financial Officer of Conexant Systems, Inc. (the “Company”). Set forth below is
the Staff’s comment contained in the Comment Letter (in bold face type) followed by
the Company’s response.
In
the Company’s response set forth below, the Company is agreeing to make revisions to
its disclosures in future filings with the SEC. Such agreement and any such revisions to
disclosures made in future filings should not be taken as an admission that prior
disclosures were in any way deficient.
Form 8-K dated April 20, 2005
1.
We
note your response and proposed disclosure to our prior comment 15. We do not
believe that the presentation of a non-GAAP statement of operations is
appropriate unless all disclosures required by Item 10(e)(1)(i) of Regulation
S-K and Question 8 of the FAQ are included for each separate non-GAAP measure.
Please delete this presentation from all future Form 8-K’s.
As
indicated in our prior comment, with respect to earnings releases furnished on Form 8-K,
if you continue to present non-GAAP information, please provide all of the disclosures
required by Item 10(e)(1)(i) of Regulation S-K for each non-GAAP measure presented. In
that regard, for each measure you should provide statements about how you use the measure
in conducting and evaluating your business, statements about why that measure provides
useful information to investors, and a quantified reconciliation to the most directly
comparable GAAP measure. Those disclosures should also address the economic substance
behind management’s decision to use each non-GAAP measure, the material limitations
associated with the use of each non-GAAP financial measure as compared to the use of the
most directly
Securities and Exchange Commission
-2-
July 25, 2005
comparable
GAAP financial measure, and the manner in which management
compensates for those limitations. Please delete the non-GAAP income statements from
future press releases or expand to fully comply with the requirements. Show us how you
intend to implement this comment.
The
Company notes the Staff’s comment and will revise its presentation of non-GAAP
financial measures in future earnings releases furnished under Item 2.02 of Form 8-K to
provide all the disclosures required by Item 10(e)(1)(i) of Regulation S-K and Question 8
of the Staff’s FAQ Regarding Use of Non-GAAP Financial Measures for each non-GAAP
financial measure presented. See the attached Appendix A for a sample of the
Company’s proposed format of earnings release tables with respect to non-GAAP
financial measures and Appendix B for a sample of Item 2.02 disclosure which would be
included in the Form 8-K filing which furnishes the earnings release document.
Please
telephone the undersigned at (949) 483-9955 or, in his absence, Mike Rispoli, Executive
Director and Corporate Controller at (949) 483-4028 if you require additional information
or wish to comment further orally. If you wish to comment further in writing, please send
such comment to the undersigned by facsimile at (949) 483-9910.
Very truly yours,
/s/ J. Scott Blouin
J. Scott Blouin
Senior Vice President and Chief Financial
Officer
Attachments
VIA EDGAR
APPENDIX A
CONEXANT SYSTEMS, INC.
GAAP Consolidated Condensed Statement of Operations
(Unaudited, in Thousands, Except Per Share Amounts)
Three months ended
Six months ended
March 31,
2005
March 31,
2004
March 31,
2005
March 31,
2004
Net revenues (See Note 1)
$
169,738
$
243,781
$
310,359
$
421,114
Cost of goods sold (See Note 2)
109,766
142,116
243,231
240,312
Gross margin
59,972
101,665
67,128
180,802
Operating expenses:
Research and development
70,539
53,734
143,080
92,888
Selling, general and administrative
28,362
30,602
58,368
53,411
Amortization of intangible assets
8,140
3,653
16,433
4,608
In-process research and development
—
160,818
—
160,818
Special charges
13,596
5,514
32,853
6,119
Total operating expenses
120,637
254,321
250,734
317,844
Operating loss
(60,665
)
(152,656
)
(183,606
)
(137,042
)
Other expense (income), net
11,892
(9,736
)
9,137
(35,017
)
Loss before income taxes
(72,557
)
(142,920
)
(192,743
)
(102,025
)
Provision for income taxes
630
459
1,162
707
Net loss
$ (73,187
)
$ (143,379
)
$ (193,905
)
$ (102,732
)
Basic and diluted loss per share
$ (0.16
)
$ (0.41
)
$ (0.41
)
$ (0.33
)
Number of shares used in per share computation
– basic and diluted
470,189
349,968
469,279
313,580
The GAAP consolidated statements of
operations include the results of operations of GlobespanVirata, Inc. from February 27,
2004, the date of the Company’s merger with GlobespanVirata. No restatement has been
made to earlier periods.
Note 1 – Includes $9.6 million
and $17.5 million of pricing adjustments to inventories in the channel during the three
and six months ended March 31, 2005, respectively.
Note 2 – Includes $45.0 million of
charges related to internal inventory in the six months ended March 31, 2005.
CONEXANT SYSTEMS, INC.
Reconciliation of Non-GAAP Core Financial Measures to GAAP Financial Measures
(Unaudited, in Thousands, Except Per Share Amounts)
Three months ended
Six months ended
March 31,
2005
March 31,
2004
March 31,
2005
March 31,
2004
GAAP operating expenses
$
120,637
$
254,321
$
250,734
$
317,844
Non-cash stock compensation (a)
(3,019
)
(1,157
)
(6,008
)
(1,180
)
Transitional salaries and benefits (b)
(4,600
)
—
(8,935
)
—
IP litigation support costs (c)
(2,148
)
(570
)
(4,345
)
(570
)
Amortization of intangible assets (d)
(8,140
)
(3,653
)
(16,433
)
(4,608
)
In-process research and development (e)
—
(160,818
)
—
(160,818
)
Special charges (f)
(13,596
)
(5,514
)
(32,853
)
(6,119
)
Non-GAAP Core operating expenses
$ 89,134
$ 82,609
$ 182,160
$ 144,549
GAAP operating loss
$ (60,665
)
$ (152,656
)
$ (183,606
)
$ (137,042
)
Operating expense adjustments described above (a-f)
31,503
171,712
68,574
173,295
Merger-related inventory impairment (g)
—
812
—
812
Non-GAAP Core operating income (loss)
$ (29,162
)
$ 19,868
$ (115,032
)
$ 37,065
GAAP net loss
$ (73,187
)
$ (143,379
)
$ (193,905
)
$ (102,732
)
Operating expense adjustments described above (a-f)
31,503
171,712
68,574
173,295
Merger-related inventory impairment (g)
—
812
—
812
Losses (earnings) of equity method investees (h)
3,371
(651
)
6,460
(10,816
)
Unrealized (gain) loss on Mindspeed warrant (i)
13,492
2,085
(1,281
)
(22,545
)
Gain on sale of equity securities (j)
(11,112
)
—
(11,112
)
—
Write-down (recovery) of investments (k)
(600
)
600
(600
)
600
Unrealized gain on note receivable from Skyworks (l)
—
(16,456
)
—
(11,545
)
Non-GAAP Core net income (loss)
$ (36,533
)
$ 14,723
$ (131,864
)
$ 27,069
Net income (loss) per share, basic:
GAAP
$ (0.16
)
$ (0.41
)
$ (0.41
)
$ (0.33
)
Non-GAAP Core (m)
$ (0.80
)
$ 0.04
$ (0.28
)
$ 0.09
Net income (loss) per share, diluted:
GAAP
$ (0.16
)
$ (0.41
)
$ (0.41
)
$ (0.33
)
Non-GAAP Core (m)
$ (0.08
)
$ 0.04
$ (0.28
)
$ 0.08
See “Non-GAAP Core to GAAP Adjustments” below.
Non-GAAP Core to GAAP
Adjustments
(a)
Non-cash stock compensation charges are based on the intrinsic value of acquired
or exchanged unvested stock options in business combinations.
(b)
Transitional salaries and benefits represent amounts earned by employees who
have been notified of their termination as part of the Company’s
restructuring activities, from the date of their notification. Included in the
amounts for the three and six months ended March 31, 2005 are $632 and $928,
respectively, of facilities related costs.
(c)
IP litigation support costs are related to one of the Company’s
intellectual property litigation matters.
(d)
Non-cash amortization of intangible assets resulting from the Company’s
previous business combinations.
(e)
In-process research and development cost was a one-time charge associated with
the Company’s merger with GlobespanVirata.
(f)
Special charges consist of asset impairments, restructuring charges, integration
costs and other special items.
(g)
Inventory impairment charge for on-hand inventory products which were determined
to be obsolete as a result of the Company’s merger with GlobespanVirata.
(h)
Non-operating gains and losses resulting from the Company’s equity method
investments.
(i)
Non-operating unrealized gains and losses associated with fair value changes in
the Company’s ownership of the Mindspeed warrant accounted for as a
derivative instrument.
(j)
Recognized gains on the sales of equity securities in publicly held companies.
(k)
Write downs or recoveries of non-marketable cost basis investments.
(l)
Non-operating unrealized gain associated with the conversion feature of the note
receivable from Skyworks which was accounted for as a derivative instrument.
(m)
In periods of net income, the dilutive effect of stock options and warrants
under the treasury stock method has been added to basic weighted average shares
to compute diluted weighted average shares. For the three and six months ended
March 31, 2004, 28,025 and 25,507 shares, respectively, have been added to
arrive at non-GAAP diluted weighted average shares.
Non-GAAP
Financial Measures
The Company has presented non-GAAP
operating expenses, non-GAAP operating income (loss), non-GAAP net income (loss) and
non-GAAP basic and diluted net income (loss) per share, on a basis consistent with its
historical presentation to assist investors in understanding the Company’s core
results of operations on an on-going basis. The non-GAAP financial measures also enhance
comparisons of the Company’s core results of operations with historical periods. The
Company is providing these non-GAAP financial measures to investors to enable them to
perform additional financial analysis and because it is consistent with the financial
models and estimates published by analysts who follow the Company. Management believes
that these are important measures in the evaluation of the Company’s results of
operations. Investors should consider non-GAAP financial measures in addition to, and not
as a substitute for, or superior to, measures of financial performance prepared in
accordance with GAAP. The non-GAAP financial measures presented by the Company may be
different than non-GAAP financial measures presented by other companies.
CONEXANT SYSTEMS, INC.
Consolidated Condensed Balance Sheets
(Unaudited, in Thousands)
March 31,
2005
December 31,
2004
September 30,
2004
ASSETS
Current assets:
Cash and cash equivalents (See Note 3)
$ 141,206
$ 132,326
$ 139,031
Marketable securities (See Note 3)
104,613
135,597
163,040
Receivables, net
94,706
92,864
185,037
Inventories
110,098
136,438
194,754
Mindspeed warrant-current portion
3,250
5,634
3,599
Other current assets
22,608
17,521
20,768
Total current assets
476,481
520,380
706,229
Property, plant and equipment, net
51,052
53,266
55,741
Goodwill
718,335
714,852
708,544
Intangible assets, net
122,597
128,947
135,241
Mindspeed warrant
24,316
35,737
23,000
Marketable securities-long term (See Note 3)
117,981
123,266
137,604
Other assets
109,049
112,936
114,163
Total assets
$1,619,811
$1,689,384
$1,880,522
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$ 92,392
$ 89,171
$ 141,533
Accrued compensation and benefits
33,708
44,511
40,423
Restructuring and reorganization liabilities
24,919
28,205
22,427
Other current liabilities
58,546
51,502
67,044
Total current liabilities
209,565
213,389
271,427
Convertible subordinated notes
711,825
711,825
711,825
Other liabilities
105,590
64,741
68,883
Total liabilities
1,026,980
989,955
1,052,135
Shareholders’ equity
592,831
699,429
828,387
Total liabilities and shareholders’ equity
$1,619,811
$1,689,384
$1,880,522
Note 3 – Total cash, cash
equivalents and marketable securities at March 31, 2005, December 31, 2004 and September
30, 2004 are as follows:
March 31,
2005
December 31,
2004
September 30,
2004
Cash and cash equivalents
$141,206
$132,326
$139,031
Other short-term marketable securities (primarily